4.5 Review

Starring stellate cells in liver immunology

期刊

CURRENT OPINION IN IMMUNOLOGY
卷 20, 期 1, 页码 68-74

出版社

CURRENT BIOLOGY LTD
DOI: 10.1016/j.coi.2007.10.006

关键词

-

向作者/读者索取更多资源

Stellate cells are star-shaped cells located in the liver and mediate a multitude of primarily non-immunological functions. They play a pivotal role in the metabolism of vitamin A and store 80% of total body retinol. Upon activation, stellate cells differentiate to myofibroblasts for production of extracellular matrix, leading to liver fibrosis. Moreover, activated stellate cells regulate liver blood flow through vasoconstriction implicated in portal hypertension. Earlier work demonstrated stellate cell derived secretion of chemokines and cytokines such as transforming growth factor beta (TGF-beta), suggesting an association with immunological processes. Indeed, recent evidence indicated that hepatic stellate cells perform potent APC function for stimulation of NKT cells as well as CD8 and CD4 T cells. Additionally, stellate cell mediated antigen presentation induced protective immunity against bacterial infection. Current experiments reveal that the presenting ability of stellate cells is the key to antigen-depenclent T cell instruction by vitamin A derived retinoic acid. Finally, future studies will show whether in the firmament of immunology stellate cells will represent fixed or falling stars.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

IL-36/LXR axis modulates cholesterol metabolism and immune defense to Mycobacterium tuberculosis

Fadhil Ahsan, Jeroen Maertzdorf, Ute Guhlich-Bornhof, Stefan H. E. Kaufmann, Pedro Moura-Alves

SCIENTIFIC REPORTS (2018)

Meeting Abstract Oncology

Preclinical evaluation of an anti-PSMA antibody-targeted amanitin conjugate (ATAC)

Aniko Palfi, Christian Breunig, Torsten Hechler, Christoph Mueller, Christian Lutz, Andreas Pahl, Michael Kulke

CANCER RESEARCH (2018)

Meeting Abstract Oncology

HDP-101: Preclinical evaluation of a novel anti-BCMA antibody drug conjugates in multiple myeloma

Andreas Pahl, Jonathan Ko, Christian Breunig, Vianiuhini Figueroa, Nicola Lehners, Anja Baumann, Aniko Palfi, Christoph Mueller, Christian Lutz, Torsten Hechler, Michael Kulke, Carsten Mueller-Tidow, Hartmut Goldschmidt, Marc Raab

JOURNAL OF CLINICAL ONCOLOGY (2018)

Article Biology

Identification of potential biomarkers of vaccine inflammation in mice

Paul F. McKay, Deniz Cizmeci, Yoann Aldon, Jeroen Maertzdorf, January Weiner, Stefan H. E. Kaufmann, David J. M. Lewis, Robert A. van den Berg, Giuseppe Del Giudice, Robin J. Shattock

Article Cell Biology

FX11 limits Mycobacterium tuberculosis growth and potentiates bactericidal activity of isoniazid through host-directed activity

Gopinath Krishnamoorthy, Peggy Kaiser, Ulrike Abu Abed, January Weiner, Pedro Moura-Alves, Volker Brinkmann, Stefan H. E. Kaufmann

DISEASE MODELS & MECHANISMS (2020)

Review Medicine, Research & Experimental

Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus

Anca Dorhoi, Leigh A. Kotze, Jay A. Berzofsky, Yongjun Sui, Dmitry I. Gabrilovich, Ankita Garg, Richard Hafner, Shabaana A. Khader, Ulrich E. Schaible, Stefan H. E. Kaufmann, Gerhard Walz, Manfred B. Lutz, Robert N. Mahon, Suzanne Ostrand-Rosenberg, William Bishai, Nelita du Plessis

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Immunology

Pregnancy has a minimal impact on the acute transcriptional signature to vaccination

John S. Tregoning, January Weiner, Deniz Cizmeci, Danielle Hake, Jeroen Maertzdorf, Stefan H. E. Kaufmann, Geert Leroux-Roels, Cathy Maes, Annelies Aerssens, Anna Calvert, Christine E. Jones

NPJ VACCINES (2020)

Article Oncology

HDP-101, an Anti-BCMA Antibody-Drug Conjugate, Safely Delivers Amanitin to Induce Cell Death in Proliferating and Resting Multiple Myeloma Cells

Vianihuini Figueroa-Vazquez, Jonathan Ko, Christian Breunig, Anja Baumann, Nicola Giesen, Aniko Palfi, Christoph Mueller, Christian Lutz, Torsten Hechler, Michael Kulke, Carsten Mueller-Tidow, Alwin Kraemer, Hartmut Goldschmidt, Andreas Pahl, Marc S. Raab

Summary: HDP-101, an anti-BCMA antibody conjugated with an amanitin derivative, demonstrates high efficacy against multiple myeloma cells while sparing BCMA-negative cells. It induces tumor regression in animal models at low doses and shows good tolerability, suggesting a promising therapeutic approach to overcome drug resistance in this disease.

MOLECULAR CANCER THERAPEUTICS (2021)

Article Immunology

Weaker protection against tuberculosis in BCG-vaccinated male 129 S2 mice compared to females

Natalie E. Nieuwenhuizen, Joanna Zyla, Ulrike Zedler, Silke Bandermann, Ulrike Abu Abed, Volker Brinkmann, Stefan H. E. Kaufmann

Summary: BCG, the only available vaccine against tuberculosis, was found to have varying efficacy against pulmonary TB based on age and sex. This study revealed that female mice had better protection from BCG vaccination against M. tuberculosis H37Rv challenge, showing lower lung bacterial burdens and less weight loss compared to male mice. It suggests the importance of including both male and female mice in preclinical testing of vaccine candidates.

VACCINE (2021)

Meeting Abstract Oncology

THE BISPECIFIC INNATE CELL ENGAGERS AFM13 (CD30/ CD16A) AND AFM24 (EGFR/CD16A) INCREASE THE FRACTION OF TUMOR TARGET-RESPONSIVE NK CELLS AND BOOST SERIAL KILLING

Chiara Zambarda, Karolin Guldevall, Chiara Zambarda, Karolin Guldevall, Christian Breunig, Damien Toullec, Jacopo Fontana, Sheena Pinto, Jens Pahl, Susanne Wingert, Joachim Koch, Bjorn Oenfelt

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Meeting Abstract Oncology

ENHANCED ANTIBODY-MEDIATED PHAGOCYTOSIS AND ANTIBODY-MEDIATED CELL CYTOTOXICITY USING TETRAVALENT, BISPECIFIC INNATE CELL ENGAGERS (ICE®) IN 3D SPHEROIDS

Sheena Pinto, Savannah Jackson, Julia Knoch, Christian Breunig, Arndt Schottelius, Joachim Koch

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Biochemistry & Molecular Biology

Vaccine-Induced Subcutaneous Granulomas in Goats Reflect Differences in Host-Mycobacterium Interactions between BCG- and Recombinant BCG-Derivative Vaccines

Elisabeth M. Liebler-Tenorio, Johannes Heyl, Nadine Wedlich, Julia Figl, Heike Koehler, Gopinath Krishnamoorthy, Natalie E. Nieuwenhuizen, Leander Grode, Stefan H. E. Kaufmann, Christian Menge

Summary: This study compares the development of tuberculous granulomas at the site of BCG vaccination and its recombinant derivatives in goats. The results show that granulomas with central caseous necrosis are induced by both BCG and its recombinant derivatives, although the size and extent of necrosis differ between vaccine strains. The recombinant derivatives induce fewer CD4(+) T and B cells and more CD8(+) cells in the granulomas compared to the parental BCG strain. Furthermore, the numbers of multinucleated giant cells (MNGCs) and cells with lipid bodies are significantly lower in groups administered with the recombinant BCG strains. These findings suggest that the granulomas induced by BCG and its recombinant derivatives in goats can serve as suitable models to compare reactions to different mycobacteria or tuberculosis vaccines.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Editorial Material Immunology

100 Years of BCG Immunization: Past, Present, and Future

Aldo Tagliabue, Diana Boraschi, Luciana C. C. Leite, Stefan H. E. Kaufmann

VACCINES (2022)

Article Biochemistry & Molecular Biology

Safety and Immunogenicity of Recombinant Bacille Calmette-Guerin Strain VPM1002 and Its Derivatives in a Goat Model

Julia Figl, Heike Koehler, Nadine Wedlich, Elisabeth M. Liebler-Tenorio, Leander Grode, Gerald Parzmair, Gopinath Krishnamoorthy, Natalie E. Nieuwenhuizen, Stefan H. E. Kaufmann, Christian Menge

Summary: A more effective vaccine against tuberculosis is urgently needed. The recombinant vaccine VPM1002 has been found to be safer and more efficacious than the existing vaccine BCG in mice models. In this study, the safety and immunogenicity of VPM1002 and its derivatives, PDX and NUOG, were assessed in juvenile goats. The results showed that VPM1002 and NUOG induced anti-tuberculous immunity with a comparable safety profile to BCG.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Meeting Abstract Oncology

AFM24 is a novel, highly potent, tetravalent bispecific EGFR/CD16A-targeting Innate Cell Engager (ICE®) designed for the treatment of EGFR-positive malignancies.

Jens Pahl, Gabriele Hintzen, Uwe Reusch, Torsten Haneke, Christian Breunig, Sheena Pinto, Cassandra Choe-Juliak, Andreas Harstrick, Wolfgang Fischer, Arndt Schottelius, Joachim Koch, Erich Rajkovic

CANCER RESEARCH (2021)

暂无数据